J
Jun Horiguchi
Researcher at Shimane University
Publications - 152
Citations - 4231
Jun Horiguchi is an academic researcher from Shimane University. The author has contributed to research in topics: Schizophrenia & Polysomnography. The author has an hindex of 29, co-authored 147 publications receiving 3798 citations.
Papers
More filters
Journal ArticleDOI
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome
Jun Horiguchi,Magdolna Hornyak,Ulrich Voderholzer,Meir H. Kryger,Robert Skomrow,Joseph F. Lipinski,Ahmed Masood,Barbara Phillips,Wolfgang H. Oertel,K. Stiasny,Shaun T. O'Keeffe,Alessandro Oldani,Marco Zucconi,William G. Ondo,Daniel L. Picchietti,J. Steven Poceta,Gerald B. Rich,Larry Scrima,Renata Shafor,Denise Sharon,Michael H. Silber,Robert C. Smith,Claudia Trenkwalder,Claudia Trenkwalder,Thomas C. Wetter,Juliane Winkelmann,Zeba Vanek,Mary L. Wagner,Arthur S. Walters +28 more
TL;DR: This scale meets performance criteria for a brief, patient completed instrument that can be used to assess RLS severity for purposes of clinical assessment, research, or therapeutic trials and supports a finding that RLS is a relatively uniform disorder in which the severity of the basic symptoms is strongly related to their impact on the patient's life.
Journal ArticleDOI
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Tsuyoshi Miyaoka,Rei Wake,Motohide Furuya,Kristian Liaury,Masa Ieda,Kazunori Kawakami,Keiko Tsuchie,Michiyo Taki,Kotomi Ishihara,Tomoko Araki,Jun Horiguchi +10 more
TL;DR: Preliminary data suggest that minocycline in combination with antidepressants is effective and well tolerated in the treatment of unipolar psychotic depression.
Journal ArticleDOI
Minocycline as adjunctive therapy for schizophrenia: an open-label study.
TL;DR: The results suggest that minocyCline may be a safe and effective adjunct to antipsychotic medications, and that augmentation with minocycline may prove to be a viable strategy for "boosting" antipsychotics efficacy and for treating schizophrenia.
Journal ArticleDOI
Possible antipsychotic effects of minocycline in patients with schizophrenia.
TL;DR: Two cases of acute schizophrenia with predominant catatonic symptoms that responded to minocycline are presented and it is reported that minocyCline might have antidepressant effects.
Journal ArticleDOI
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Tsuyoshi Miyaoka,Misako Kanayama,Rei Wake,Sadayuki Hashioka,Maiko Hayashida,Michiharu Nagahama,Shihoh Okazaki,Satoko Yamashita,Shoko Miura,Hiroyuki Miki,Hiroyuki Matsuda,Masahiro Koike,Muneto Izuhara,Tomoko Araki,Keiko Tsuchie,Ilhamuddin Abdul Azis,Ryosuke Arauchi,Rostia Arianna Abdullah,Arata Oh-Nishi,Jun Horiguchi +19 more
TL;DR: Preliminary data suggest that CBM588 in combination with antidepressants is effective and well tolerated in the treatment of TRD.